MobiHealth News May 3, 2024
The open-source gene editor is freely available to license for commercial use and ethical research.
AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, developed more than a decade ago, allows scientists to modify DNA sequences within living organisms precisely.
Potential applications range from treatments for genetic disorders to researching disease mechanisms.
The molecules it designs are fully synthetic and do not exist in nature, in contrast to previous technologies in gene editing, such as CRISPR-Cas9.
The company is open-sourcing OpenCRISPR-1 for free ethical research and commercial use...
Today's Sponsors
Today's Sponsor